Crossmark

Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation

Crossref DOI link: https://doi.org/10.1007/s13311-020-00992-6

Published Print: 2021-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Bamia, Aline

Sinane, Maha

Naït-Saïdi, Rima

Dhiab, Jamila

Keruzoré, Marc

Nguyen, Phu Hai

Bertho, Agathe

Soubigou, Flavie

Halliez, Sophie

Blondel, Marc

Trollet, Capucine

Simonelig, Martine

Friocourt, Gaëlle

Béringue, Vincent

Bihel, Frédéric

Voisset, Cécile https://orcid.org/0000-0001-7505-1927
Funding

Funding for this research was provided by:

Institut de France – Fondation NRJ

MESR

MESR

Inserm

Inserm

UBO

CNRS

University of Montpellier

AFM-Téléthon eOPMD (17110)

AFM-Téléthon eOPMD (17110)

Sorbonne Université

Association Institut de Myologie

DIM MALINF

INRAE

Fondation pour la Recherche Médicale (DEQ20150331689)

AFM-Téléthon

Association Défi Organisation
License Information

Text and Data Mining valid from 2021-04-01

Text and Data Mining valid from 2021-04-01

Version of Record valid from 2023-08-18
More Information

This article is maintained by: Elsevier

Article Title: Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation

Journal Title: Neurotherapeutics

CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-020-00992-6

Content Type: article

Copyright: Copyright © 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.